Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
NICE recommends GLP-1 receptor agonists for type 2 diabetes when metformin and other oral medications fail to achieve adequate glycaemic control, particularly with BMI 35 kg/m or weight-related comorbidities
Reduced Appetite and Smaller Meal Tolerance Support Demand GLP-1 users often consume less food per sitting, yet they still need nutrient intake that feels reliable
With that weight loss comes lower cholesterol levels and improved blood pressure and blood sugar, all contributing to lower cardiovascular risk
In some cases, gallstones may need to be removed surgically if they are causing significant discomfort or complications
Unlike the aforementioned, a lower rate of MACE than placebo was not observed
MONTH 2 3+ Studies suggest fine lines and elasticity benefits become more apparent with consistent daily use
